The Present and Future
JACC State-of-the-Art Review
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations

https://doi.org/10.1016/j.jacc.2018.09.072Get rights and content
Under an Elsevier user license
open archive

Abstract

This JACC Scientific Expert Panel provides consensus recommendations for an update of the cardiovascular magnetic resonance (CMR) diagnostic criteria for myocardial inflammation in patients with suspected acute or active myocardial inflammation (Lake Louise Criteria) that include options to use parametric mapping techniques. While each parameter may indicate myocardial inflammation, the authors propose that CMR provides strong evidence for myocardial inflammation, with increasing specificity, if the CMR scan demonstrates the combination of myocardial edema with other CMR markers of inflammatory myocardial injury. This is based on at least one T2-based criterion (global or regional increase of myocardial T2 relaxation time or an increased signal intensity in T2-weighted CMR images), with at least one T1-based criterion (increased myocardial T1, extracellular volume, or late gadolinium enhancement). While having both a positive T2-based marker and a T1-based marker will increase specificity for diagnosing acute myocardial inflammation, having only one (i.e., T2-based OR T1-based) marker may still support a diagnosis of acute myocardial inflammation in an appropriate clinical scenario, albeit with less specificity. The update is expected to improve the diagnostic accuracy of CMR further in detecting myocardial inflammation.

Key Words

cardiovascular magnetic resonance
myocardial inflammation
myocarditis

Abbreviations and Acronyms

AUC
area-under-the-curve
AUC*
estimated area-under-the-curve
CMR
cardiovascular magnetic resonance
ECG
electrocardiogram
ECV
extracellular volume
EGE
early gadolinium enhancement
EMB
endomyocardial biopsy
ESC
European Society of Cardiology
GBCA
gadolinium-based contrast agent
LGE
late gadolinium enhancement
MR
magnetic resonance

Cited by (0)

Dr. Ferreira acknowledges support from the National Institute of Health Research Biomedical Research Centre, Oxford, and the British Heart Foundation Centre of Research Excellence, Oxford. Dr. Friedrich is a board member, adviser, and shareholder of Circle Cardiovascular Imaging. Dr. Kramer is a consultant for Bayer Healthcare; and has received a research grant from Biotelemetry. Dr. Schulz-Menger is a consultant for Bayer Healthcare and Siemens Healthineers. Dr. Gutberlet has received moderate speaker honoraria from Bayer, Bracco, Siemens, and Philips. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Listen to this manuscript's audio summary by Editor-in-Chief Dr. Valentin Fuster on JACC.org.